secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001193125-26-106144
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharma sets 2026 annual meeting for June 2; record date April 7
---------------------------------------------------------------------

- Annual meeting scheduled for June 2, 2026.
- Record date for notice and voting is April 7, 2026.
- Company will use notice-and-access for both registered and non-registered investors.
- Only common shares are entitled to vote at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000119312526106144/0001193125-26-106144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000119312526106144/xene-20260313.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-106144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer